Börse Express – New York Stocks: Moderate Gains

NEW YORK (dpa-AFX) – The record run on the US stock exchanges continued with small steps on Tuesday. Just the Dow Jones Industrial
continues to lag behind. Around two hours before the close of trading, the world’s most famous Wall Street index rose by a low 0.07 percent to 34,308.16 points. Its moderate profits at the start of trading have largely crumbled.

The market-wide S&P 500 stepped on the spot with plus 0.03 percent to 4291.94 points after breaking the 4300 point mark in early trading for the first time in its history. Likewise, the Nasdaq stock exchanges, which are mainly peppered with technology stocks, topped their records and were able to hold them. The Nasdaq 100 selection index most recently advanced by 0.20 percent to 14,553.51 points.

The economic data hardly moved. The real estate market continues to record strong price increases. In addition, the mood of US consumers surprisingly brightened significantly and rose again to the level shortly before the Corona crisis. “Even if the mood recovery is impressive, it is only partially reflected in the spending behavior of consumers,” said market analyst Michael Hewson from CMC Markets and recalled the fall in retail sales in May.

On the corporate side, the focus was primarily on the banking sector. The leading Wall Street banks want to distribute more money to shareholders after passing the stress test. Morgan Stanley
about wants to double the quarterly dividend to 70 US cents and use up to twelve billion dollars for share buybacks. The papers put in the S&P 100 by 3.6 percent.

Also the Dow members Goldman Sachs and JPMorgan
are looking to hike their dividend, bringing Goldman stock up 1.2 percent, while JPMorgan stock’s earnings vanished into thin air. Citigroup’s paper
, which does not want to change its previous plans for the time being, lost 1.8 percent at the same time.

The Moderna share also came into focus , which jumped to a record high and was most recently at the top of the Nasdaq 100, an increase of 5.7 percent. It benefited from the fact that India has now also approved the US biotech company’s corona vaccine. In addition, according to the company, the Moderna vaccine also stimulates an immune response against the Corona variant Delta (B.1.617.2), which first appeared in India./ck/men

 ISIN  US2605661048  US6311011026  US78378X1072

AXC0342 2021-06-29/20:08

Copyright dpa-AFX Wirtschaftsnachrichten GmbH. All rights reserved. Redistribution, republication or permanent storage without the express prior consent of dpa-AFX is not permitted.

– .